Overview

Reducing Blood Loss Using Tisseel in TKA

Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of the topical hemostatic agents in patients receiving primary TKA procedures. The investigators will also observe if there is increased risk of blood transfusion rate by using topical hemostatic agents or not.
Phase:
Phase 4
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Treatments:
Fibrin Tissue Adhesive
Tranexamic Acid